Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: BD MAX MRSA; SIRS-Lab Sepsis Test

Premium

Becton Dickinson said this week that its BD MAX MRSA molecular test has received a CLIA moderate complexity rating.

Performed on the automated BD MAX system, the assay is designed to rapidly and accurately identify patients colonized with methicillin-resistant Staphylococcus aureus. A moderate complexity rating allows the BD MAX MRSA assay to be performed by a qualified laboratory technician.

Earlier this year, the BD MAX GBS assay for Group B Streptococcus received a moderate complexity rating.


Germany's SIRS-Lab said this week that it has completed recruitment for a 1,000-patient trial to evaluate its Vyoo pathogen-detection assay for patients with suspected sepsis.

The prospective, blinded multicenter study focused on ICU patients at 13 key medical centers across Germany, SIRS-Lab said.

The Vyoo molecular test combines highly multiplexed qPCR with microarray analysis to identify molecular signatures of a variety of pathogens implicated in sepsis. The assay also uses a proprietary sample prep method that concentrates pathogen DNA from complex samples such as whole blood.

SIRS-Lab commenced the trial in March (PCR Insider, 3/24/2012). At the time, the company said that results would be available this year. This week, however, the company said that it expects results from the trial in 2013.

SIRS-Lab obtained CE marking for the current Vyoo test in May 2012. The company said this week that it has continued to invest in further automating Vyoo, reducing hands-on time for laboratory technicians to 70 minutes per run with an overall test time of seven hours.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.